EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Formulation and characterization of chitosan nanoparticles to enhance transdermal delivery of cinnarizine.

Omar A Hamid, Fadia Y Albazzaz, Rasha K Dhahir

International Journal of Pharmaceutical Excipients · 24.09.2023 · 14 (3)

DOI: 10.66617/001c.88226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Excipients, online erschienen am 24.09.2023. Verfasst von Omar A Hamid und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cinnarizine (CN) is an antihistaminic drug that is commonly used for the treatment of chronic conditions for the reduction of cerebral blood flow such as vertigo. However, CN is poorly water soluble with erratic absorption and low bioavailability. Chitosan is a biodegradable natural polymer with approved skin permeation enhancement properties; therefore, the formulation of CN-loaded chitosan nanoparticles could enhance the skin permeability of CN. In this work, for the first time, CN-loaded chitosan nanoparticles were prepared (using the nanoprecipitation method) and characterized. Additionally, the described nanoparticles were subjected to in vitro release and ex vivo permeation studies. Dynamic light scattering (DLS) characterization showed that the method was successful in the production of small (down to 12.4 nm), positive, and relatively homogenous or monodispersed nanoparticles. The highest entrapment efficiency (EE) of CN in the chitosan nanoparticles was 62±2.7%. Further, the release study showed that chitosan nanoparticles can effectively reduce the burst release and create a sustained release pattern of CN. The ex vivo permeation study, using rat skin as a model, showed that chitosan nanoparticles improved the CN permeability three times compared to the control. In conclusion, chitosan used as a nanocarrier enhances drug penetration in to the skin which may lead to the formulation of a transdermal formulation of CN

Zitieren

APA

Hamid, O. A., Albazzaz, F. Y., & Dhahir, R. K. (2023). Formulation and characterization of chitosan nanoparticles to enhance transdermal delivery of cinnarizine. International Journal of Pharmaceutical Excipients, 14(3). https://doi.org/10.66617/001c.88226

Vancouver

Hamid OA, Albazzaz FY, Dhahir RK. Formulation and characterization of chitosan nanoparticles to enhance transdermal delivery of cinnarizine. International Journal of Pharmaceutical Excipients. 2023;14(3). doi:10.66617/001c.88226

BibTeX
@article{Hamid2023,
  author = {Hamid, Omar A and Albazzaz, Fadia Y and Dhahir, Rasha K},
  title = {Formulation and characterization of chitosan nanoparticles to enhance transdermal delivery of cinnarizine},
  journal = {International Journal of Pharmaceutical Excipients},
  year = {2023},
  volume = {14},
  number = {3},
  doi = {10.66617/001c.88226}
}
Kostenlos starten →